{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:25:32Z","timestamp":1787739932519,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ando.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T19:05:02Z","timestamp":1537211102000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature"],"prefix":"10.1016","volume":"80","author":[{"given":"Salwan","family":"Maqdasy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Desbiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathana\u00eblle","family":"Montanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Batisse-Lignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tauveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2018.05.001_bib0315","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/01.CIR.93.12.2128","article-title":"Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators","volume":"93","author":"Massie","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2018.05.001_bib0320","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMct065916","article-title":"Amiodarone for atrial fibrillation","volume":"356","author":"Zimetbaum","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0325","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0330","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2018.05.001_bib0335","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.300.15.1784","article-title":"Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial","volume":"300","author":"Ahmed","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2018.05.001_bib0340","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association","volume":"61","author":"Bartalena","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0345","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists","volume":"69","author":"Tanda","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0350","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","article-title":"Determinants and outcome of amiodarone-associated thyroid dysfunction","volume":"75","author":"Ahmed","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0355","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","article-title":"Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome","volume":"49","author":"Conen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ando.2018.05.001_bib0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","article-title":"Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome","volume":"94","author":"Yiu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","author":"Daniels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0370","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjmed.2003.09.036","article-title":"Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis","volume":"116","author":"Hermida","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0380","first-page":"207","article-title":"Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131","volume":"97","author":"Hermida","year":"2004","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.ando.2018.05.001_bib0385","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.amjcard.2016.01.003","article-title":"Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction","volume":"117","author":"Maqdasy","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ando.2018.05.001_bib0390","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/circ.105.11.1275","article-title":"Successful treatment of amiodarone-induced thyrotoxicosis","volume":"105","author":"Osman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2018.05.001_bib0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.72.3.266","article-title":"Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued","volume":"72","author":"Trip","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.ando.2018.05.001_bib0400","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0410","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.1.02122","article-title":"Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality","volume":"154","author":"O'Sullivan","year":"2006","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1016\/j.ando.2018.05.001_bib0415","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","article-title":"The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type","volume":"171","author":"Tomisti","year":"2014","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1016\/j.ando.2018.05.001_bib0425","first-page":"1153","article-title":"Cardiac consequences of clinical dysthyroidism","volume":"34","author":"Vinzio","year":"2005","journal-title":"Pathophysiological, clinical, and epidemiologic data. Presse Medicale Paris Fr"},{"key":"10.1016\/j.ando.2018.05.001_bib0430","first-page":"192","article-title":"Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone","volume":"28","author":"Jonckheer","year":"1973","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ando.2018.05.001_bib0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0300-0664.2001.01458.x","article-title":"Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge","volume":"56","author":"Bartalena","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0440","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0445","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.05.001_bib0450","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0455","doi-asserted-by":"crossref","first-page":"20160836","DOI":"10.1259\/bjr.20160836","article-title":"Evaluation of (99) Tc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis","volume":"90","author":"Wang","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ando.2018.05.001_bib0460","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.05.001_bib0465","first-page":"1402","article-title":"Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis","volume":"26","author":"Martino","year":"1985","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0470","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem-63-2-485","article-title":"Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism","volume":"63","author":"Wiersinga","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0475","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002018-200629030-00006","article-title":"Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis","volume":"29","author":"Uzan","year":"2006","journal-title":"Drug Saf Int J Med Toxicol Drug Exp"},{"key":"10.1016\/j.ando.2018.05.001_bib0485","first-page":"805","article-title":"Treatment of amiodarone-induced hyperthyroidism: corticosteroids or potassium perchlorate? What value do interleukin-6 levels have?","volume":"117","author":"Martin-Du Pan","year":"1997","journal-title":"Rev Med Suisse Romande"},{"key":"10.1016\/j.ando.2018.05.001_bib0490","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2009-0940","article-title":"Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study","volume":"94","author":"Bogazzi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0495","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","article-title":"Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole","volume":"9","author":"Martino","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2018.05.001_bib0500","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/bmj.298.6687.1547","article-title":"Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment","volume":"298","author":"Reichert","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2018.05.001_bib0505","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1445-5994.2003.00463.x","article-title":"Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response","volume":"33","author":"Wong","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.ando.2018.05.001_bib0510","doi-asserted-by":"crossref","first-page":"405411","DOI":"10.1007\/s11096-013-9910-9","article-title":"Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study","volume":"36","author":"Huang","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ando.2018.05.001_bib0515","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-08-0553","article-title":"Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?","volume":"159","author":"Tanda","year":"2008","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1016\/j.ando.2018.05.001_bib0520","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-17-0018","article-title":"The Clinical Value of Regular Thyroid Function Tests During Amiodarone Treatment","volume":"177","author":"Benjamens","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.05.001_bib0525","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"et al., 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.05.001_bib0530","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1590\/S0100-879X2009000800009","article-title":"How frequently should a patient taking amiodarone be screened for thyroid dysfunction?","volume":"42","author":"Pazin-Filho","year":"2009","journal-title":"Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol"},{"key":"10.1016\/j.ando.2018.05.001_bib0535","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jc.2012-1797","article-title":"Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction","volume":"97","author":"Tomisti","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0540","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.05.001_bib0545","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","article-title":"Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease","volume":"30","author":"Gough","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2018.05.001_bib0550","first-page":"45","article-title":"Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State","volume":"124","author":"Kaderli","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc"},{"key":"10.1016\/j.ando.2018.05.001_bib0555","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/PL00024613","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective?","volume":"22","author":"Hamoir","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2018.05.001_bib0560","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2018.05.001_bib0565","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jca.21309","article-title":"Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report","volume":"29","author":"Yamamoto","year":"2014","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.ando.2018.05.001_bib0570","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1017\/S0022215112000722","article-title":"Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?","volume":"126","author":"Pierret","year":"2012","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.ando.2018.05.001_bib0575","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1444-0903.2004.00600.x","article-title":"Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis","volume":"34","author":"Diamond","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.ando.2018.05.001_bib0580","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jca.20200","article-title":"Preoperative therapeutic plasma exchange in patients with thyrotoxicosis","volume":"24","author":"Ezer","year":"2009","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.ando.2018.05.001_bib0585","first-page":"327","article-title":"The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study","volume":"48","author":"Keklik","year":"2013","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.ando.2018.05.001_bib0590","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7326\/0003-4819-131-1-199907060-00023","article-title":"Plasmapheresis in thyrotoxicosis","volume":"131","author":"Ligtenberg","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0595","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2265.2008.03405.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis (AIT)","volume":"70","author":"Albino","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0600","first-page":"133","volume":"72","author":"Bogazzi","year":"2010","journal-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note. Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.05.001_bib0605","first-page":"121","article-title":"Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy","volume":"79","author":"Newman","year":"1998","journal-title":"Heart Br Card Soc"},{"key":"10.1016\/j.ando.2018.05.001_bib0610","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2018.05.001_bib0615","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40618-015-0426-0","article-title":"The presence of anti-thyroglobulin (TgAb) and\/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis","volume":"39","author":"Tomisti","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2018.05.001_bib0620","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/105072504322880391","volume":"14","author":"Ryan","year":"2004","journal-title":"Am Thyroid Assoc"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:51:19Z","timestamp":1757717479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426618300945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0003426618300945"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2018.05.001","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}